Table: begin end state 1 13 non-cytoplasmic 14 33 transmembrane 34 65 cytoplasmic 66 87 transmembrane 88 92 non-cytoplasmic 93 111 transmembrane 112 142 cytoplasmic 143 161 transmembrane 162 179 non-cytoplasmic 180 199 transmembrane 200 208 cytoplasmic 209 228 transmembrane 229 246 non-cytoplasmic 247 266 transmembrane 267 302 cytoplasmic 303 323 transmembrane 324 343 non-cytoplasmic 344 369 transmembrane 370 388 cytoplasmic 389 410 transmembrane 411 418 non-cytoplasmic 419 442 transmembrane 443 463 cytoplasmic
Input: >WP_011989076.1 NCBI__GCF_000016505.1:WP_011989076.1 MEGLINALNSIDSILWGVPMIVVLFGTHIFFTFRTGFIQKKIFTGIKLSVTKDPDGEGDV SQFGALSTALAATIGTGNIIGVATAVTLGGPGAVLWMWFTGVFGIATKYAESLISVKYRV KTEDGTMLGGAMYALEKGLKMKWLGVIFCIFTALAAFGIGCSTQTNAVASTLHNSFGIPT WISGIVIAIFVGAVVIGGVQSITKVCEKLVPFMAIFYVLGCLIILVMNADVLGQTVVTIV KAAFSPQAAGGGFIGSTVAIACRYGAARGLFSNESGMGSAPIVAAAAKTKNPVRQALVSM TGTFWDTVVICLMTGLVIVSSVIKNPAIDTKTSSLLTSAAWDQIPVIGPIIIAIALAIFA LSTVLGWSYYGERAAEYLFGKKIIKPYRVAWVIVALIGTLVSLDLVWTIADILNALMVIP NVIAMMVIPNVIAMFLLSGVIAAETKKYVNNLDLPSEDKEKVS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server